Cogent Biosciences (COGT) shares have surged after pivotal bezuclastinib data in imatinib-resistant aGIST. Read the latest ...
Researchers at the Technical University of Munich (TUM) have developed a method for diagnosing urinary tract infections that significantly accelerates antibiotic resistance testing in urine. Because ...
One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...
The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy ...
Researchers at the Technical University of Munich (TUM) have developed a method for diagnosing urinary tract infections that ...
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...
DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a leader in rapid eye based diagnostic technologies, is pleased to announce that the Company has signed a ...
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...
One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own ...
News-Medical.Net on MSN
Novel cryo-EM findings could revolutionize T cell immunotherapy design
One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...
Explore how Nobel laureates Ilya Mechnikov and Paul Ehrlich revolutionized immunology, shaping modern medicine and public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback